Pharsight

Drugs that contain Beclomethasone Dipropionate

1. Qnasl patents expiration

QNASL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5605674 TEVA BRANDED PHARM Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US5683677 TEVA BRANDED PHARM Medicinal aerosol formulations
Nov, 2014

(9 years ago)

US5776432 TEVA BRANDED PHARM Beclomethasone solution aerosol formulations
Jul, 2015

(8 years ago)

US7780038 TEVA BRANDED PHARM Dispensing apparatus with dosage counter
Jan, 2027

(2 years from now)

US10188811 TEVA BRANDED PHARM Nasal spray device
Oct, 2031

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Strength(NS) Dec 17, 2017
New Product(NP) Mar 23, 2015

Market Authorisation Date: 17 December, 2014

Treatment: NA

Dosage: AEROSOL, METERED;NASAL

More Information on Dosage

QNASL family patents

Family Patents

2. Qvar 40 patents expiration

QVAR 40 IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5605674 TEVA BRANDED PHARM Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US5683677 TEVA BRANDED PHARM Medicinal aerosol formulations
Nov, 2014

(9 years ago)

US5776432 TEVA BRANDED PHARM Beclomethasone solution aerosol formulations
Jul, 2015

(8 years ago)

US6446627 TEVA BRANDED PHARM Inhaler dose counter
Dec, 2017

(6 years ago)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US11395889 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses
May, 2031

(6 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

Market Authorisation Date: 15 September, 2000

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of QVAR 40 before it's drug patent expiration?
More Information on Dosage

QVAR 40 family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Qvar 80 patents expiration

QVAR 80 IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5605674 TEVA BRANDED PHARM Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US5683677 TEVA BRANDED PHARM Medicinal aerosol formulations
Nov, 2014

(9 years ago)

US5776432 TEVA BRANDED PHARM Beclomethasone solution aerosol formulations
Jul, 2015

(8 years ago)

US6446627 TEVA BRANDED PHARM Inhaler dose counter
Dec, 2017

(6 years ago)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses
May, 2031

(6 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US11395889 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

Market Authorisation Date: 15 September, 2000

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of QVAR 80 before it's drug patent expiration?
More Information on Dosage

QVAR 80 family patents

Family Patents

4. Qvar Redihaler patents expiration

QVAR REDIHALER IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6446627 NORTON WATERFORD Inhaler dose counter
Dec, 2017

(6 years ago)

US7637260 NORTON WATERFORD Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
Aug, 2020

(3 years ago)

US8132712 NORTON WATERFORD Metered-dose inhaler
Sep, 2028

(4 years from now)

US11395889 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022510 NORTON WATERFORD Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10695512 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022509 NORTON WATERFORD Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10086156 NORTON WATERFORD Dose counter for inhaler and method for counting doses
May, 2031

(6 years from now)

US8931476 NORTON WATERFORD Inhaler
Jul, 2031

(7 years from now)

US10561808 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US11865247 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US11793953 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US11896759 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US11395888 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US10792447 NORTON WATERFORD Breath actuated inhaler
Jan, 2039

(14 years from now)

US11559637 NORTON WATERFORD Inhalers and related methods
Jul, 2039

(15 years from now)

US11583643 NORTON WATERFORD Inhalers and related methods
Aug, 2041

(17 years from now)

Market Authorisation Date: 03 August, 2017

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

QVAR REDIHALER family patents

Family Patents